Intravenous contrast media in uroradiology: Evaluation of safety and tolerability in almost 50,000 patients

Medical Principles and Practice

Volumn 15, Issue 5, 2006, Pages 358-361

  Wendt Nordahl, Gunnar ^a   Rotert, Harald ^b   Trojan, Lutz ^a   Michel, Maurice Stephan ^a   Peters, Candida R ^c   Alken, Peter ^a   Knoll, Thomas ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KRANKENHAUS NORDWEST   (Germany)

^c Guerbet GmbH   (Germany)

Author keywords

Contrast media, safety; Intravenous urography, adverse events; Lobitridol

Indexed keywords

ANTIHISTAMINIC AGENT; CONTRAST MEDIUM; CORTICOSTEROID; IOBITRIDOL;

ADOLESCENT; ADULT; AGED; ANAPHYLACTIC SHOCK; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; DIZZINESS; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FLUSHING; HUMAN; INTRAVENOUS UROGRAPHY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; NAUSEA; POSTMARKETING SURVEILLANCE; PRURITUS; RASH; UROLITHIASIS; URTICARIA; VOMITING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; DRUG HYPERSENSITIVITY; FEMALE; GERMANY; HUMANS; INJECTIONS, INTRAVENOUS; IOHEXOL; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; RISK FACTORS; SAFETY; UROGRAPHY;

EID: 33746932137     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094269     Document Type: Article

References (13)

1. Deray G, Dubois M, Martinez F, Jacobs C: Radiocontrast nephrotoxicity in rats: a new model of acute renal failure. Am J Nephrol 1990;10:507-513.
2. Deray G, Bellin MF, Zaim S, Raymond F, Grellet J, Jacobs C: Evaluation of the renal tolerance of Xenetix in patients with chronic renal failure. Nephron 1998;80:240.
3. Wasaki M, Kawamura H, Sugimoto J, Shimada M, Satoh Y, Tanaka E, Gemba M: Comparative toxic effects on iobitridol and iohexol on the kidney. Invest Radiol 1998;33:393-400.
4. Wolf GL, Arenson RL, Cross A: A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: comparison of side effects. Am J Roentgenol 1989;152:939-944.
5. Fournier PJ, Steinbrich W, Freitag P, Voegeli: Evaluation of the clinical safety and efficacy of iobitridol (Xenetix) in intravenous urography. Eur Radiol 1996;23:185-189.
6. Meiss L, Bakker AJ, Falke THM, van Waes PFGM: Clinical safety and efficacy of iobitridol in urography. Acta Radiol Suppl 1996;400:68-71.
7. Dencausse A, Violas X, Feldman H, Havard P, Chambon C: Pharmacokinetic profile of iobitridol. Acta Radiol Suppl 1996;400:25-34.
8. Idee JM, Balut C, Beaufils H, et al: Pharmacologic profile of iobitridol, a nonionic iodinated contrast medium. Acta Radiol Suppl 1996;400:35.
9. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Matsuura K: Adverse reactions to ionic and nonionic contrast media. Radiology 1990;175:621-628.
10. Petersein J, Peters CR, Wolf M, Hamm B: Results of the safety and efficacy of iobitridol in more than 61,000 patients. Eur Radiol 2003;13:2006-2011.
11. Cochran ST, Bomyea K, Sayre JW: Trends in adverse events after intravenous administration of contrast media. Am J Radiol 2001;176:1385-1388.
12. Lasser EC, Lyon SG, Berry CC: Reports on contrast media reactions: analysis of data from reports to the US Food and Drug Administration. Radiology 1997;203:605-610.
13. Spring DB, Bettmann MA, Barkan HE: Deaths related to iodinated contrast media reported spontaneously to the US Food and Drug Administration, 1978-1994: effect of the availability of low-osmolality contrast media. Radiology 1997;204:333-337.